188 related articles for article (PubMed ID: 28194565)
1. Transgenic papaya: a useful platform for oral vaccines.
Fragoso G; Hernández M; Cervantes-Torres J; Ramírez-Aquino R; Chapula H; Villalobos N; Segura-Velázquez R; Figueroa A; Flores I; Jiménez H; Adalid L; Rosas G; Galvez L; Pezzat E; Monreal-Escalante E; Rosales-Mendoza S; Vazquez LG; Sciutto E
Planta; 2017 May; 245(5):1037-1048. PubMed ID: 28194565
[TBL] [Abstract][Full Text] [Related]
2. Development of the S3Pvac vaccine against murine Taenia crassiceps cysticercosis: a historical review.
Sciutto E; Fragoso G; Hernández M; Rosas G; Martínez JJ; Fleury A; Cervantes J; Aluja A; Larralde C
J Parasitol; 2013 Aug; 99(4):693-702. PubMed ID: 23409920
[TBL] [Abstract][Full Text] [Related]
3. Development of the S3Pvac vaccine against porcine Taenia solium cysticercosis: a historical review.
Sciutto E; Fragoso G; Hernández M; Rosas G; Martínez JJ; Fleury A; Cervantes J; Aluja A; Larralde C
J Parasitol; 2013 Aug; 99(4):686-92. PubMed ID: 23445359
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic capacity of the synthetic peptide-based vaccine against Taenia solium cysticercosis in pigs.
de Aluja AS; Villalobos NM; Nava G; Toledo A; Martínez JJ; Plancarte A; Rodarte LF; Fragoso G; Sciutto E
Vaccine; 2005 Jul; 23(31):4062-9. PubMed ID: 15927324
[TBL] [Abstract][Full Text] [Related]
5. Recombinant bacteriophage-based multiepitope vaccine against Taenia solium pig cysticercosis.
Manoutcharian K; Díaz-Orea A; Gevorkian G; Fragoso G; Acero G; González E; De Aluja A; Villalobos N; Gómez-Conde E; Sciutto E
Vet Immunol Immunopathol; 2004 May; 99(1-2):11-24. PubMed ID: 15113650
[TBL] [Abstract][Full Text] [Related]
6. Towards the development of an oral vaccine against porcine cysticercosis: expression of the protective HP6/TSOL18 antigen in transgenic carrots cells.
Monreal-Escalante E; Govea-Alonso DO; Hernández M; Cervantes J; Salazar-González JA; Romero-Maldonado A; Rosas G; Garate T; Fragoso G; Sciutto E; Rosales-Mendoza S
Planta; 2016 Mar; 243(3):675-85. PubMed ID: 26613600
[TBL] [Abstract][Full Text] [Related]
7. Induction of protection against porcine cysticercosis by vaccination with recombinant oncosphere antigens.
Flisser A; Gauci CG; Zoli A; Martinez-Ocaña J; Garza-Rodriguez A; Dominguez-Alpizar JL; Maravilla P; Rodriguez-Canul R; Avila G; Aguilar-Vega L; Kyngdon C; Geerts S; Lightowlers MW
Infect Immun; 2004 Sep; 72(9):5292-7. PubMed ID: 15322025
[TBL] [Abstract][Full Text] [Related]
8. Improvement of the synthetic tri-peptide vaccine (S3Pvac) against porcine Taenia solium cysticercosis in search of a more effective, inexpensive and manageable vaccine.
Sciutto E; Rosas G; Hernández M; Morales J; Cruz-Revilla C; Toledo A; Manoutcharian K; Gevorkian G; Blancas A; Acero G; Hernández B; Cervantes J; Bobes RJ; Goldbaum FA; Huerta M; Diaz-Orea A; Fleury A; de Aluja AS; Cabrera-Ponce JL; Herrera-Estrella L; Fragoso G; Larralde C
Vaccine; 2007 Feb; 25(8):1368-78. PubMed ID: 17188784
[TBL] [Abstract][Full Text] [Related]
9. Inexpensive anti-cysticercosis vaccine: S3Pvac expressed in heat inactivated M13 filamentous phage proves effective against naturally acquired Taenia solium porcine cysticercosis.
Morales J; Martínez JJ; Manoutcharian K; Hernández M; Fleury A; Gevorkian G; Acero G; Blancas A; Toledo A; Cervantes J; Maza V; Quet F; Bonnabau H; de Aluja AS; Fragoso G; Larralde C; Sciutto E
Vaccine; 2008 Jun; 26(23):2899-905. PubMed ID: 18440675
[TBL] [Abstract][Full Text] [Related]
10. Experimental and Theoretical Approaches To Investigate the Immunogenicity of Taenia solium-Derived KE7 Antigen.
Bobes RJ; Navarrete-Perea J; Ochoa-Leyva A; Anaya VH; Hernández M; Cervantes-Torres J; Estrada K; Sánchez-Lopez F; Soberón X; Rosas G; Nunes CM; García-Varela M; Sotelo-Mundo RR; López-Zavala AA; Gevorkian G; Acero G; Laclette JP; Fragoso G; Sciutto E
Infect Immun; 2017 Dec; 85(12):. PubMed ID: 28923896
[No Abstract] [Full Text] [Related]
11. DNA vaccine against Taenia solium cysticercosis expressed as a modified hepatitis B virus core particle containing three epitopes shared by Taenia crassiceps and Taenia solium.
Wu L; Diao Z; Deng X; Gao J; Zhou Z; Liu Y; Wang Y
J Nanosci Nanotechnol; 2005 Aug; 5(8):1204-10. PubMed ID: 16193978
[TBL] [Abstract][Full Text] [Related]
12. Protection of pigs against Taenia solium cysticercosis using recombinant antigen or in combination with DNA vaccine.
Guo YJ; Sun SH; Zhang Y; Chen ZH; Wang KY; Huang L; Zhang S; Zhang HY; Wang QM; Wu D; Zhu WJ
Vaccine; 2004 Sep; 22(29-30):3841-7. PubMed ID: 15364430
[TBL] [Abstract][Full Text] [Related]
13. Transplastomic plants yield a multicomponent vaccine against cysticercosis.
Rosales-Mendoza S; Monreal-Escalante E; González-Ortega O; Hernández M; Fragoso G; Garate T; Sciutto E
J Biotechnol; 2018 Jan; 266():124-132. PubMed ID: 29253519
[TBL] [Abstract][Full Text] [Related]
14. A new highly effective anticysticercosis vaccine expressed in transgenic papaya.
Hernández M; Cabrera-Ponce JL; Fragoso G; López-Casillas F; Guevara-García A; Rosas G; León-Ramírez C; Juárez P; Sánchez-García G; Cervantes J; Acero G; Toledo A; Cruz C; Bojalil R; Herrera-Estrella L; Sciutto E
Vaccine; 2007 May; 25(21):4252-60. PubMed ID: 17399859
[TBL] [Abstract][Full Text] [Related]
15. Induction of protection against porcine cysticercosis in growing pigs by DNA vaccination.
Guo A; Jin Z; Zheng Y; Hai G; Yuan G; Li H; Cai X
Vaccine; 2007 Jan; 25(1):170-5. PubMed ID: 16750874
[TBL] [Abstract][Full Text] [Related]
16. Protection of pigs against Taenia solium cysticercosis by immunization with novel recombinant antigens.
Gauci CG; Jayashi CM; Gonzalez AE; Lackenby J; Lightowlers MW
Vaccine; 2012 Jun; 30(26):3824-8. PubMed ID: 22521850
[TBL] [Abstract][Full Text] [Related]
17. Fact or hypothesis: Taenia crassiceps as a model for Taenia solium, and the S3Pvac vaccine.
Lightowlers MW
Parasite Immunol; 2010; 32(11-12):701-9. PubMed ID: 21039610
[TBL] [Abstract][Full Text] [Related]
18. Towards a Taenia solium cysticercosis vaccine: an epitope shared by Taenia crassiceps and Taenia solium protects mice against experimental cysticercosis.
Toledo A; Larralde C; Fragoso G; Gevorkian G; Manoutcharian K; Hernández M; Acero G; Rosas G; López-Casillas F; Garfias CK; Vázquez R; Terrazas I; Sciutto E
Infect Immun; 1999 May; 67(5):2522-30. PubMed ID: 10225916
[TBL] [Abstract][Full Text] [Related]
19. Two epitopes shared by Taenia crassiceps and Taenia solium confer protection against murine T. crassiceps cysticercosis along with a prominent T1 response.
Toledo A; Fragoso G; Rosas G; Hernández M; Gevorkian G; López-Casillas F; Hernández B; Acero G; Huerta M; Larralde C; Sciutto E
Infect Immun; 2001 Mar; 69(3):1766-73. PubMed ID: 11179354
[TBL] [Abstract][Full Text] [Related]
20. Antibody responses and epitope specificities to the Taenia solium cysticercosis vaccines TSOL18 and TSOL45-1A.
Kyngdon CT; Gauci CG; Gonzalez AE; Flisser A; Zoli A; Read AJ; Martínez-Ocaña J; Strugnell RA; Lightowlers MW
Parasite Immunol; 2006 May; 28(5):191-9. PubMed ID: 16629704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
